Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM8HVNR)

Drug Name

Recombinant acidic fibroblast growth factor Drug Info

Synonyms

AFGF; Rh-aFGF; Recombinant acidic fibroblast growth factor (ulcer/burns); Recombinant acidic fibroblast growth factor (ulcer/burns), SinoBiomed; Recombinant acidic fibroplast growth factor (ulcer/burns), SinoBiomed

Indication

Disease Entry	ICD 11	Status	REF
Skin burns	ME65.0	Phase 3	[1]

Cross-matching ID

TTD Drug ID: DM8HVNR

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Fibroblast growth factor (FGF)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Futibatinib	DMWM4D0	Intrahepatic cholangiocarcinoma	2C12.10	Approved	[3]
GSK3052230	DMCKNJX	Solid tumour/cancer	2A00-2F9Z	Phase 1	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fibroblast growth factor (FGF)	TT5HU6Z	NOUNIPROTAC	Modulator	[2]

------------------------------------------------------------------------------------

References

1	Pharmacokinetic Properties of 2nd-Generation Fibroblast Growth Factor-1 Mutants for Therapeutic Application. November 1, 2012.
2	Molecular characterization of recombinant human acidic fibroblast growth factor produced in E. coli: comparative studies with human basic fibroblast growth factor. Mol Endocrinol. 1990 Jun;4(6):869-79.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	National Cancer Institute Drug Dictionary (drug id 599037).